You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Advanced small cell lung cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Small Cell Lung Cancer Trial (Tarlatamab)

Available
  • Small Cell Lung Cancer
  • (no location specified)
Sep 26, 2023

Small Cell Lung Cancer, Neuroendocrine Carcinoma Trial in Chiba, Tokyo (RO7616789, Tocilizumab)

Recruiting
  • Small Cell Lung Cancer
  • Neuroendocrine Carcinoma
  • Chiba, Japan
  • +1 more
Jan 16, 2023

Locally Advanced Alveolar Soft Part Sarcoma, Metastatic Alveolar Soft Part Sarcoma, Locally Advanced Non Small Cell Lung Cancer

Not yet recruiting
  • Locally Advanced Alveolar Soft Part Sarcoma
  • +9 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Oct 10, 2023

Small Cell Lung Carcinoma (SCLC) Trial (BI 764532, Carboplatin, Etoposide)

Not yet recruiting
  • Small Cell Lung Carcinoma (SCLC)
  • BI 764532
  • +5 more
  • (no location specified)
Oct 17, 2023

Metabolic Response to Food in Advanced Lung Cancer

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Weight loss (%)
  • (no location specified)
Jun 30, 2023

Treatment Patterns in Advanced Small Cell Lung Cancer (SCLC)

Completed
  • Lung Cancer
    • Barcelona, Spain
    • +1 more
    Jan 11, 2022

    T-Cell Repertoire Sequencing: Assessing Pembrolizumab Efficacy

    Not yet recruiting
    • Non-small Cell Lung Cancer Metastatic
      • (no location specified)
      Sep 13, 2023

      Untreated Advanced NSCLC Trial in Fuzhou (Recombinant human adenovirus type 5 injection (H101) combined with tirilizumab and

      Recruiting
      • Untreated Advanced Non-small Cell Lung Cancer
      • Recombinant human adenovirus type 5 injection (H101) combined with tirilizumab and platinum-containing two-drug chemotherapy
      • Fuzhou, Fujian, China
        Fujian Cancer Hospital
      Nov 13, 2023

      Advanced Non-small-cell Lung Cancer Trial in Shanghai (AK112, AK104, caboplatin)

      Not yet recruiting
      • Advanced Non-small-cell Lung Cancer
      • Shanghai, China
        Shanghai Pulmonary Hospital
      Jun 6, 2023

      Nonsmall Cell Lung Cancer Trial in Shanghai (HS-10365 capsules)

      Recruiting
      • Nonsmall Cell Lung Cancer
      • HS-10365 capsules
      • Shanghai, Shanghai, China
        Shanghai Chest Hospital
      Nov 22, 2023

      NSCLC Trial in Guangzhou (BL-M07D1)

      Not yet recruiting
      • Non-small Cell Lung Cancer
      • Guangzhou, Guangdong, China
        Sun Yat-sen University Cancer Center
      Nov 1, 2023

      Non Small Cell Lung Cancer, Locally Advanced, Radiotherapy Trial in Wuhan (CTV omitted or delineated)

      Not yet recruiting
      • Non Small Cell Lung Cancer
      • +3 more
      • CTV omitted or delineated
      • Wuhan, Hubei, China
        Hubei Cancer Hospital
      Sep 1, 2023

      Nonsmall Cell Lung Cancer, Nonsmall Cell Lung Cancer, Stage II, Nonsmall Cell Lung Cancer Stage III Trial in Tampa (Genomically

      Recruiting
      • Nonsmall Cell Lung Cancer
      • +3 more
      • Genomically Guided Radiation Therapy (RT)
      • Tampa, Florida
        Moffitt Cancer Center
      May 23, 2023

      NSCLC, NSCLC Trial in Guangzhou (Apatinib + Fluzoparib, Apatinib + Fluzoparib + Adebrelimab)

      Not yet recruiting
      • NSCLC
      • Non-small Cell Lung Cancer
      • Apatinib + Fluzoparib
      • Apatinib + Fluzoparib + Adebrelimab
      • Guangzhou, Guangdong, China
        Sun Yat-Sen University Cancer Center
      Jun 27, 2023

      Locally Advanced or Metastatic NSCLC Trial (HB1801, Taxotere)

      Not yet recruiting
      • Locally Advanced or Metastatic Non-Small Cell Lung Cancer
      • (no location specified)
      May 8, 2023

      NSCLC Trial (Tislelizumab IV, Tislelizumab SC, Histology-Based Chemotherapy Doublet)

      Not yet recruiting
      • Non-small Cell Lung Cancer
      • Tislelizumab IV
      • +2 more
      • (no location specified)
      Oct 25, 2023

      Non-Small-Cell Lung Cancer Trial in Guangzhou (PLB1004)

      Recruiting
      • Non-Small-Cell Lung Cancer
      • Guangzhou, Guangdong, China
        Guangdong General Hospital
      Aug 25, 2023

      ALK Positive NSCLC Trial in Guangzhou (Loratinib)

      Recruiting
      • ALK Positive Non-small Cell Lung Cancer
      • Guangzhou, Guangdong, China
        Guangdong Provincial Perople's Hospital
      Oct 19, 2023

      NSCLC Trial in Shanghai (SI-B001, SI-B003)

      Not yet recruiting
      • Non-small Cell Lung Cancer
      • Shanghai, Shanghai, China
        Shanghai Pulmonary Hospital
      Jul 10, 2023

      Non Small Cell Lung Cancer, Propranolol Trial (Propranolol HCl, Sintilimab, Chemotherapy)

      Not yet recruiting
      • Non Small Cell Lung Cancer
      • Propranolol
      • Propranolol hydrochloride
      • +2 more
      • (no location specified)
      Jul 31, 2023

      Lung Cancer Trial (exercise)

      Not yet recruiting
      • Lung Cancer
      • exercise
      • (no location specified)
      Jul 17, 2023

      Advanced NSCLC Trial in Jinan (almonertinib)

      Recruiting
      • Advanced Non-small Cell Lung Cancer
      • Jinan, Shandong, China
        Degan Lu
      Sep 12, 2023

      Non Small Cell Lung Cancer Trial (TGRX-326, Crizotinib)

      Not yet recruiting
      • Non Small Cell Lung Cancer
      • (no location specified)
      Oct 8, 2023

      Advanced Squamous Non-Small-Cell Lung Cancer Trial (Trilaciclib, Carboplatin, Paclitaxel)

      Not yet recruiting
      • Advanced Squamous Non-Small-Cell Lung Cancer
      • (no location specified)
      Jun 11, 2023

      Advanced NSCLC With KRAS G12C Mutation Trial in New York (Sotorasib, Ladarixin)

      Not yet recruiting
      • Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation
      • New York, New York
        NYU Langone Health
      Apr 4, 2023